Brandon Capital Announces Sixth Fund with A$270 million (US$180 million) Initial Close to Drive Life Science Innovation FOR IMMEDIATE RELEASE - 9:00 AM AEST MELBOURNE 4 JUNE 2024 AND 19.00 PM EDT NEW YORK 3 JUNE MELBOURNE, Australia, June 04, 2024 (GLOBE NEWSWIRE) -- Brandon Capital, Australasia’s leading life...

Brandon Capital Joins AstronauTx’ £48 million ($61 million) Series A Financing to Create New Treatments for Alzheimer’s disease Australian Venture Capital firm Brandon Capital invests in AstronauTx, a UK-based biotech company developing novel treatments for Alzheimer’s disease